secobarbital will minimize the extent or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Consider an increase in cannabidiol dosage (according to clinical response and tolerability) when coadministered with a strong CYP3A4 inducer.The authors, editors, producers, and contributors